News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
848,698 Results
Type
Article (86582)
Company Profile (702)
Press Release (761414)
Multimedia
Podcasts (133)
Webinars (16)
Section
Business (232722)
Career Advice (4128)
Deals (39729)
Drug Delivery (129)
Drug Development (91003)
Employer Resources (198)
FDA (18128)
Job Trends (17342)
News (396549)
Policy (39764)
Tag
Academia (3001)
Academic (2)
Accelerated approval (7)
Adcomms (31)
Allergies (96)
Alliances (56872)
ALS (108)
Alzheimer's disease (1520)
Antibody-drug conjugate (ADC) (167)
Approvals (18075)
Artificial intelligence (350)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (89)
Brain cancer (33)
Breast cancer (328)
Cancer (2580)
Cardiovascular disease (217)
Career advice (3535)
Career pathing (34)
CAR-T (187)
Cell therapy (523)
Cervical cancer (22)
Clinical research (73624)
Collaboration (961)
Company closure (2)
Compensation (603)
Complete response letters (30)
COVID-19 (2879)
CRISPR (57)
C-suite (289)
Cystic fibrosis (111)
Data (2511)
Decentralized trials (2)
Denatured (46)
Depression (58)
Diabetes (313)
Diagnostics (6943)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (158)
Drug pricing (138)
Drug shortages (33)
Duchenne muscular dystrophy (111)
Earnings (97365)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130543)
Executive appointments (821)
FDA (19629)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (867)
Gene editing (133)
Generative AI (36)
Gene therapy (391)
GLP-1 (873)
Government (5184)
Grass and pollen (6)
Guidances (176)
Healthcare (20895)
Huntington's disease (26)
IgA nephropathy (32)
Immunology and inflammation (158)
Immuno-oncology (2)
Indications (31)
Infectious disease (3045)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (61)
Intellectual property (106)
Interviews (813)
IPO (17853)
IRA (52)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (569)
Leadership (24)
Legal (10121)
Liver cancer (82)
Lung cancer (364)
Lymphoma (174)
Machine learning (9)
Management (65)
Manufacturing (386)
MASH (88)
Medical device (14657)
Medtech (14662)
Mergers & acquisitions (22484)
Metabolic disorders (840)
Multiple sclerosis (93)
NASH (23)
Neurodegenerative disease (126)
Neuropsychiatric disorders (36)
Neuroscience (2171)
NextGen: Class of 2025 (7683)
Non-profit (5084)
Now hiring (42)
Obesity (446)
Opinion (279)
Ovarian cancer (86)
Pain (106)
Pancreatic cancer (91)
Parkinson's disease (173)
Partnered (25)
Patents (268)
Patient recruitment (127)
Peanut (51)
People (65418)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22725)
Phase II (31984)
Phase III (24068)
Pipeline (1538)
Policy (189)
Postmarket research (3552)
Preclinical (10269)
Press Release (72)
Prostate cancer (117)
Psychedelics (39)
Radiopharmaceuticals (271)
Rare diseases (455)
Real estate (7393)
Recruiting (75)
Regulatory (26877)
Reports (61)
Research institute (2661)
Resumes & cover letters (649)
Rett syndrome (7)
RNA editing (8)
RSV (51)
Schizophrenia (84)
Series A (150)
Series B (100)
Service/supplier (30)
Sickle cell disease (61)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (77)
Tariffs (59)
The Weekly (85)
Vaccines (833)
Venture capitalists (47)
Weight loss (309)
Women's health (42)
Worklife (20)
Date
Today (152)
Last 7 days (795)
Last 30 days (3927)
Last 365 days (35502)
2025 (14237)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (63)
Alaska (7)
Arizona (272)
Arkansas (14)
Asia (50231)
Australia (8846)
California (7011)
Canada (2172)
China (600)
Colorado (300)
Connecticut (316)
Delaware (175)
Europe (115302)
Florida (1024)
Georgia (237)
Hawaii (1)
Idaho (65)
Illinois (662)
India (31)
Indiana (351)
Iowa (13)
Japan (189)
Kansas (115)
Kentucky (28)
Louisiana (16)
Maine (72)
Maryland (1017)
Massachusetts (5346)
Michigan (261)
Minnesota (443)
Mississippi (2)
Missouri (94)
Montana (32)
Nebraska (26)
Nevada (75)
New Hampshire (70)
New Jersey (1947)
New Mexico (31)
New York (1966)
North Carolina (1179)
North Dakota (10)
Northern California (3019)
Ohio (234)
Oklahoma (15)
Oregon (48)
Pennsylvania (1515)
Puerto Rico (15)
Rhode Island (36)
South America (1653)
South Carolina (29)
South Dakota (1)
Southern California (2585)
Tennessee (112)
Texas (1050)
United States (26591)
Utah (205)
Virginia (189)
Washington D.C. (74)
Washington State (634)
West Virginia (3)
Wisconsin (76)
There are 848,698 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
May 22, 2025
·
1 min read
Press Releases
Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting
May 22, 2025
·
5 min read
Press Releases
CEL-SCI Announces Proposed Public Offering - May 21, 2025
May 22, 2025
·
4 min read
Press Releases
Thermo Fisher Scientific Declares Quarterly Dividend - May 21, 2025
May 22, 2025
·
1 min read
Press Releases
Avenzo Therapeutics Announces FDA Clearance of Investigational New Drug Application for AVZO-023 (ARTS-023), a Potential Best-in-Class, Novel CDK4 Selective Inhibitor
May 22, 2025
·
2 min read
Press Releases
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
May 22, 2025
·
9 min read
Press Releases
Celltrion’s YUFLYMA® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths
May 22, 2025
·
17 min read
Press Releases
AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients
May 22, 2025
·
4 min read
Press Releases
Fourth NDA for Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation
May 22, 2025
·
6 min read
Press Releases
CEL-SCI Announces Pricing of Public Offering - May 21, 2025
May 22, 2025
·
4 min read
1 of 84,870
Next
